- IKK2
-
IKK-β also known as inhibitor of nuclear factor kappa-B kinase subunit beta is a protein that in humans is encoded by the IKBKB (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta) gene.
Contents
Function
Main article: IκB kinaseIKK-β is an enzyme that serves as a protein subunit of IκB kinase, which is a component of the cytokine-activated intracellular signaling pathway involved in triggering immune responses. Its activity causes activation of a transcription factor known as Nuclear Transcription factor kappa-B or NF-κB. Activated IKK-β phosphorylates a protein called the inhibitor of NF-κB, IκB (IκBα), which binds NF-κB to inhibit its function. Phosphorylated IκB is degraded via the ubiquitination pathway, freeing NF-κB, and allowing its entry into the nucleus of the cell where it activates various genes involved in inflammation and other immune responses.
Clinical significance
IKK-β plays a significant role in brain cells following a stroke. citation needed, Oct 2011. If NF-κB inhibition by IKK-β is blocked, damaged cells within the brain stay alive, and according to a study performed by the University of Heidelberg and the University of Ulm, the cells even appear to make some recovery.[1] The size of the infarct, or tissue killed or damaged by ischemia, is reduced in mice in which IKK-β has been blocked.[2] Additionally, experimental mice with an overactive form of IKK-β experience loss of many more neurons than normal mice after a stroke-simulating event.[1] Researchers found a molecule that could block the signaling of IKK-β for up to four and a half hours.[3] In another study, researchers found that inhibiting IKK-β prevented kidney and wasting diseases in an animal model used to study wasting diseases of human AIDS sufferers.[4]
Interactions
IKK-β (IKBKB) has been shown to interact with
References
- ^ a b BBC News. 14 November 2005. Stroke 'cell-death trigger' found. Retrieved on June 28, 2007.
- ^ Schwaninger, M; Inta, I; Herrmann, O (2006). "NF-kappaB signalling in cerebral ischaemia". Biochemical Society transactions 34 (Pt 6): 1291–4. doi:10.1042/BST0341291. PMID 17073804.
- ^ Herrmann, O; Baumann, B; De Lorenzi, R; Muhammad, S; Zhang, W; Kleesiek, J; Malfertheiner, M; Köhrmann, M et al. (2005). "IKK mediates ischemia-induced neuronal death". Nature medicine 11 (12): 1322–9. doi:10.1038/nm1323. PMID 16286924.
- ^ Heckmann A, Waltzinger C, Jolicoeur P, Dreano M, Kosco-Vilbois MH, and Sagot Y. 2004. IKK-β Inhibitor Alleviates Kidney and Wasting Diseases in a Murine Model of Human AIDS. American Journal of Pathology. Volume 164, Pages 1253-1262. Retrieved on June 30, 2007.
- ^ a b c Chen, Guoqing; Cao Ping, Goeddel David V (Feb. 2002). "TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90". Mol. Cell (United States) 9 (2): 401–10. doi:10.1016/S1097-2765(02)00450-1. ISSN 1097-2765. PMID 11864612.
- ^ Zandi, E; Rothwarf D M, Delhase M, Hayakawa M, Karin M (Oct. 1997). "The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation". Cell (UNITED STATES) 91 (2): 243–52. doi:10.1016/S0092-8674(00)80406-7. ISSN 0092-8674. PMID 9346241.
- ^ a b Otsuki, Tetsuya; Young David B, Sasaki Dennis T, Pando Matthew P, Li Jianwu, Manning Anthony, Hoekstra Merl, Hoatlin Maureen E, Mercurio Frank, Liu Johnson M (2002). "Fanconi anemia protein complex is a novel target of the IKK signalsome". J. Cell. Biochem. (United States) 86 (4): 613–23. doi:10.1002/jcb.10270. ISSN 0730-2312. PMID 12210728.
- ^ May, M J; D'Acquisto F, Madge L A, Glöckner J, Pober J S, Ghosh S (Sep. 2000). "Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex". Science (UNITED STATES) 289 (5484): 1550–4. doi:10.1126/science.289.5484.1550. ISSN 0036-8075. PMID 10968790.
- ^ a b c d Woronicz, J D; Gao X, Cao Z, Rothe M, Goeddel D V (Oct. 1997). "IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK". Science (UNITED STATES) 278 (5339): 866–9. doi:10.1126/science.278.5339.866. ISSN 0036-8075. PMID 9346485.
- ^ a b Deng, L; Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen Z J (Oct. 2000). "Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain". Cell (UNITED STATES) 103 (2): 351–61. doi:10.1016/S0092-8674(00)00126-4. ISSN 0092-8674. PMID 11057907.
- ^ Yeung, K C; Rose D W, Dhillon A S, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W, Sedivy J M (Nov. 2001). "Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation". Mol. Cell. Biol. (United States) 21 (21): 7207–17. doi:10.1128/MCB.21.21.7207-7217.2001. ISSN 0270-7306. PMC 99896. PMID 11585904. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=99896.
- ^ Lamberti, C; Lin K M, Yamamoto Y, Verma U, Verma I M, Byers S, Gaynor R B (Nov. 2001). "Regulation of beta-catenin function by the IkappaB kinases". J. Biol. Chem. (United States) 276 (45): 42276–86. doi:10.1074/jbc.M104227200. ISSN 0021-9258. PMID 11527961.
- ^ Chariot, Alain; Leonardi Antonio, Muller Jurgen, Bonif Marianne, Brown Keith, Siebenlist Ulrich (Oct. 2002). "Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases". J. Biol. Chem. (United States) 277 (40): 37029–36. doi:10.1074/jbc.M205069200. ISSN 0021-9258. PMID 12133833.
- ^ a b Wu, Ray-Chang; Qin Jun, Hashimoto Yoshihiro, Wong Jiemin, Xu Jianming, Tsai Sophia Y, Tsai Ming-Jer, O'Malley Bert W (May. 2002). "Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase". Mol. Cell. Biol. (United States) 22 (10): 3549–61. doi:10.1128/MCB.22.10.3549-3561.2002. ISSN 0270-7306. PMC 133790. PMID 11971985. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=133790.
- ^ Shifera, Amde Selassie; Horwitz Marshall S (Mar. 2008). "Mutations in the zinc finger domain of IKK gamma block the activation of NF-kappa B and the induction of IL-2 in stimulated T lymphocytes". Mol. Immunol. (England) 45 (6): 1633–45. doi:10.1016/j.molimm.2007.09.036. ISSN 0161-5890. PMID 18207244.
- ^ Vig, E; Green M, Liu Y, Yu K Y, Kwon H J, Tian J, Goebl M G, Harrington M A (Mar. 2001). "SIMPL is a tumor necrosis factor-specific regulator of nuclear factor-kappaB activity". J. Biol. Chem. (United States) 276 (11): 7859–66. doi:10.1074/jbc.M010399200. ISSN 0021-9258. PMID 11096118.
- ^ Windheim, Mark; Stafford Margaret, Peggie Mark, Cohen Philip (Mar. 2008). "Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase". Mol. Cell. Biol. (United States) 28 (5): 1783–91. doi:10.1128/MCB.02380-06. PMC 2258775. PMID 18180283. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2258775.
- ^ Mercurio, F; Murray B W, Shevchenko A, Bennett B L, Young D B, Li J W, Pascual G, Motiwala A, Zhu H, Mann M, Manning A M (Feb. 1999). "IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex". Mol. Cell. Biol. (UNITED STATES) 19 (2): 1526–38. ISSN 0270-7306. PMC 116081. PMID 9891086. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=116081.
- ^ Cohen, L; Henzel W J, Baeuerle P A (Sep. 1998). "IKAP is a scaffold protein of the IkappaB kinase complex". Nature (ENGLAND) 395 (6699): 292–6. doi:10.1038/26254. ISSN 0028-0836. PMID 9751059.
- ^ Luftig, M A; Cahir-McFarland E, Mosialos G, Kieff E (May. 2001). "Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40". J. Biol. Chem. (United States) 276 (18): 14602–6. doi:10.1074/jbc.C100103200. ISSN 0021-9258. PMID 11278268.
- ^ Heissmeyer, V; Krappmann D, Hatada E N, Scheidereit C (Feb. 2001). "Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha". Mol. Cell. Biol. (United States) 21 (4): 1024–35. doi:10.1128/MCB.21.4.1024-1035.2001. ISSN 0270-7306. PMC 99557. PMID 11158290. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=99557.
- ^ Heissmeyer, V; Krappmann D, Wulczyn F G, Scheidereit C (Sep. 1999). "NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes". EMBO J. (ENGLAND) 18 (17): 4766–78. doi:10.1093/emboj/18.17.4766. ISSN 0261-4189. PMC 1171549. PMID 10469655. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1171549.
- ^ Prajapati, Shashi; Verma Udit, Yamamoto Yumi, Kwak Youn Tae, Gaynor Richard B (Jan. 2004). "Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity". J. Biol. Chem. (United States) 279 (3): 1739–46. doi:10.1074/jbc.M306273200. ISSN 0021-9258. PMID 14585847.
- ^ Zhang, S Q; Kovalenko A, Cantarella G, Wallach D (Mar. 2000). "Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation". Immunity (UNITED STATES) 12 (3): 301–11. doi:10.1016/S1074-7613(00)80183-1. ISSN 1074-7613. PMID 10755617.
- ^ Chaudhary, P M; Eby M T, Jasmin A, Kumar A, Liu L, Hood L (Sep. 2000). "Activation of the NF-kappaB pathway by caspase 8 and its homologs". Oncogene (ENGLAND) 19 (39): 4451–60. doi:10.1038/sj.onc.1203812. ISSN 0950-9232. PMID 11002417.
- ^ Devin, A; Lin Y, Yamaoka S, Li Z, Karin M, Liu Zg (Jun. 2001). "The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF". Mol. Cell. Biol. (United States) 21 (12): 3986–94. doi:10.1128/MCB.21.12.3986-3994.2001. ISSN 0270-7306. PMC 87061. PMID 11359906. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=87061.
- ^ Li, Shitao; Wang Lingyan, Dorf Martin E (Jan. 2009). "PKC phosphorylation of TRAF2 mediates IKKalpha/beta recruitment and K63-linked polyubiquitination". Mol. Cell (United States) 33 (1): 30–42. doi:10.1016/j.molcel.2008.11.023. PMC 2643372. PMID 19150425. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2643372.
See also
Kinases: Serine/threonine-specific protein kinases (EC 2.7.11-12) Serine/threonine-specific protein kinases (EC 2.7.11.1-EC 2.7.11.20) Non-specific serine/threonine protein kinases (EC 2.7.11.1)Pyruvate dehydrogenase kinase (EC 2.7.11.2)Dephospho-(reductase kinase) kinase (EC 2.7.11.3)(isocitrate dehydrogenase (NADP+)) kinase (EC 2.7.11.5)(tyrosine 3-monooxygenase) kinase (EC 2.7.11.6)Myosin-heavy-chain kinase (EC 2.7.11.7)Fas-activated serine/threonine kinase (EC 2.7.11.8)Goodpasture-antigen-binding protein kinase (EC 2.7.11.9)-IκB kinase (EC 2.7.11.10)cAMP-dependent protein kinase (EC 2.7.11.11)cGMP-dependent protein kinase (EC 2.7.11.12)Protein kinase C (EC 2.7.11.13)Rhodopsin kinase (EC 2.7.11.14)Beta adrenergic receptor kinase (EC 2.7.11.15)G-protein coupled receptor kinases (EC 2.7.11.16)Ca2+/calmodulin-dependent (EC 2.7.11.17)BRSK2, CAMK1, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CAMK4, MLCK, CASK, CHEK1, CHEK2, DAPK1, DAPK2, DAPK3, STK11, MAPKAPK2, MAPKAPK3, MAPKAPK5, MARK1, MARK2, MARK3, MARK4, MELK, MKNK1, MKNK2, NUAK1, NUAK2, OBSCN, PASK, PHKG1, PHKG2, PIM1, PIM2, PKD1, PRKD2, PRKD3, PSKH1, SNF1LK2, KIAA0999, STK40, SNF1LK, SNRK, SPEG, TSSK2, Kalirin, TRIB1, TRIB2, TRIB3, TRIO, Titin, DCLK1Myosin light-chain kinase (EC 2.7.11.18)MYLK, MYLK2, MYLK3, MYLK4Phosphorylase kinase (EC 2.7.11.19)Elongation factor 2 kinase (EC 2.7.11.20)Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30) Polo kinase (EC 2.7.11.21)Cyclin-dependent kinase (EC 2.7.11.22)(RNA-polymerase)-subunit kinase (EC 2.7.11.23)Mitogen-activated protein kinase (EC 2.7.11.24)Extracellular signal-regulated (MAPK1, MAPK3, MAPK4, MAPK6, MAPK7, MAPK12, MAPK15), C-Jun N-terminal (MAPK8, MAPK9, MAPK10), P38 mitogen-activated protein (MAPK11, MAPK13, MAPK14)MAP3K (EC 2.7.11.25)Tau-protein kinase (EC 2.7.11.26)(acetyl-CoA carboxylase) kinase (EC 2.7.11.27)-Tropomyosin kinase (EC 2.7.11.28)-Low-density-lipoprotein receptor kinase (EC 2.7.11.29)-Receptor protein serine/threonine kinase (EC 2.7.11.30)Dual-specificity kinases (EC 2.7.12) Categories:- Human proteins
- Cell signaling
- Signal transduction
- Neurology
- Cellular neuroscience
- Programmed cell death
Wikimedia Foundation. 2010.